1
0
0
News
Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax...
investor.cyclacel.com
William G. Wierda, Daniella Zheleva and William Plunkett.
Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With
www.globenewswire.com
Suppression of both BCl-2 and Mcl-1 anti-apoptotic proteins is a novel strategy in CLL...
Cyclacel's CYC065 Featured in Presentations at the American ...www.globenewswire.com › news-release ›
www.globenewswire.com
Authors: Chiara Saladino, Sheelagh Frame, Susan Davis, David Blake, Daniella Zheleva, Cyclacel Limited, Dundee, UK. Abstract:
Cyclacel’s Second-Generation CDK2/9 Inhibitor, CYC065, is an...
www.globenewswire.com
Preclinical Data Presented at the AACR Meeting
Network Profiles
LinkedIn: Daniella Zheleva | LinkedIn
View Daniella Zheleva’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Daniella Zheleva discover ...
Interests
LandOfFree - Inventor - Daniella Zheleva
canadianpatents.landoffree.com
Check out Daniella Zheleva. Rate and share your experience with other people.
Business Profiles
patentbuddy: Daniella I Zheleva
CYCLACEL LIMITED, Fife, GB
Education
Biomedical Papers: AURORA KINASES: STRUCTURE, FUNCTIONS AND THEIR...
biomed.papers.upol.cz
Reviewers For Biomedical Papers. January ... Madhu Kollareddy a, Petr Dzubak a, Daniella Zheleva b, Marian Hajduch a a Laboratory of Experimental Medicine, ...
Property
BRPI COMPOSTOS DE...
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Books & Literature
Daniella Zheleva | Semantic Scholar
www.semanticscholar.org
Semantic Scholar profile for Daniella Zheleva, with 1 highly influential citations and 7 scientific research papers.
Daniella Zheleva | XanEdu Customization Platform
www.academicpub.com
Author: Daniella Zheleva. Results. An integrated pharmacokinetic– pharmacodynamic model for an Aurora kinase inhibitor Springer Science +Business ...
authors:"Daniella Zheleva" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
AACR 2016: Abstracts American Association for Cancer...
books.google.fr
The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...
Related Documents
Daniella Ivanova ZHELEVA - Personal Appointments (free information...
find-and-update.company-information.service.gov.uk
Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity
CiteSeerX — An integrated pharmacokinetic–pharmacodynamic model for...
citeseerx.ist.psu.edu
@MISC{Kamei_anintegrated, author = {Hiroko Kamei and Robert C. Jackson and Daniella Zheleva and Fordyce A. Davidson and H. Kamei F. A. Davidson and R. C. Jackson ...
Daniella Zheleva - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
CLP | Certificate of Lawfulness -...
planning.fife.gov.uk
Applicant Name, Mr Nikolia & Daniella Zheleva. Agent Name, Keith Edwards. Agent Company Name, Keith Edwards Architect. Agent Address, 2 Caledon Street ...
Scientific Publications
Orally bioavailable CDK9/2 inhibitor shows PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
... Nathanael S Gray , Julian Blagg , Simon P Robinson , Suzanne A Eccles , Daniella Zheleva , James E Bradner , Jan Molenaar , Igor Vivanco ...
Publications
In vitro and in vivo antitumor properties of the cyclin dependent...
core.ac.uk
· In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R ... Wang, Nikolai Zhelev, Daniella Zheleva and ...
Publications Authored by Daniella Zheleva | PubFacts
www.pubfacts.com
Publications Authored by Daniella Zheleva
Cancers | Free Full-Text | Implementing Patient-Derived ...www.mdpi.com › xml
www.mdpi.com
Daniella Zheleva. 6,. Jochen H. M. Prehn. 1,. Markus Rehm. 7,8,. Annette T. Byrne. 1,‡ and. Brona M. Murphy. 1,*,‡. 1. Department of Physiology & Medical ...
Aurora kinase inhibitors: Progress towards the clinic ...link.springer.com › article
link.springer.com
Daniella Zheleva ,; Petr Dzubak ,; Pathik Subhashchandra Brahmkshatriya ,; […] ...
Reports & Statements
JISCMail - CCP4BB Archives
www.jiscmail.ac.uk
21 Sep Posted on behalf of Daniella Zheleva: Cyclacel Ltd has a fully operational high brilliance Rigaku crystallography system for sale. ...
TwitLonger — When you talk too much for Twitter
www.twitlonger.com
TwitLonger is the easy way to post more than 140 characters to Twitter
CrossRef Cited By Search Results : nature.com
www.nature.com
Nature - the world's best science and medicine on your desktop
[ccp4bb] crystallography system for sale
www.mail-archive.com
Posted on behalf of Daniella Zheleva: Cyclacel Ltd has a fully operational high brilliance Rigaku crystallography system for sale. The system ...
Miscellaneous
EP A1 - Dosage regimen for sapacitabine and seliciclib ...
patents.google.com
Daniella Zheleva: Susan Davis: Simon Green: Geoffrey Shapiro; Current ...
Cyclacel’s Second-Generation CDK Yahoo Finance
finance.yahoo.com
Apr 18, · Sheelagh M. Frame, Elizabeth Pohler, Craig MacKay, Daniella Zheleva, ... How the Brexit vote is inconveniencing rich art buyers Sponsored Yahoo Finance ...
DR DANIELLA ZHELEVA director information. Free director information....
companycheck.co.uk
DR DANIELLA ZHELEVA - INACTIVE - Director ID is And address is 46 Seymour Street, Dundee, DD2 1HA - A free Director Summary including all company...
Zheleva Namensbedeutung und -herkunft - Namespediade.namespedia.com › details › Zheleva
de.namespedia.com
Daniella Zheleva (1) Maria Zheleva (1) Mariyana Zheleva (1) Svetla Zheleva (1) Tanya Zheleva (1) Stanislava Zheleva (1) Pepa Zheleva (1) Mihaela Zheleva (1)
EP A1 - Dosage regimen for sapacitabine and ...www.google.com › patents
patents.google.com
... Judy Chiao: David Blake: Daniella Zheleva: Susan Davis: Simon Green: Geoffrey Shapiro; Current Assignee (The listed assignees may be inaccurate. Google ...
WO A2 - Pyridinyl - or pyrimidinyl thiazoles with protein...
patents.google.com
Inventors, Kenneth Duncan, Peter Fischer, Darren Gibson, Shudong Wang, Daniella Zheleva. Applicant, Cyclacel Ltd, Kenneth Duncan, Peter ...
Daniella Zheleva profile | free company director checkwww.companydirectorcheck.com › amp › daniella-zhel...
www.companydirectorcheck.com
Daniella Zheleva Company Director Profile. Past and present positions of Daniella Zheleva. List of companies where Daniella Zheleva holds appointments.
CA A1 - Bisarylsulfonamide compounds and their use in cancer...
patents.google.com
Inventors, Shudong Wang, Darren Gibson, Kenneth Duncan, Kevin Bailey, Mark Thomas, David Maccallum, Daniella Zheleva, Nicholas John ...
CA A1 - Pyridinyl - or pyrimidinyl thiazoles with protein...
patents.google.com
Inventors, Kenneth Duncan, Darren Gibson, Shudong Wang, Daniella Zheleva, Peter Fischer. Applicant, Cyclacel Limited, Kenneth Duncan, Darren Gibson, ...
WO A heteroaryl pyrimidine derivatives and use thereof...
patents.google.com
Inventors, Gavin Wood, Christopher Keith Meades, Peter Fischer, Shudong Wang, Kenneth Duncan, Daniella Zheleva, Campbell Mcinnes, Mark Thomas.
DANIELLA ZHELEVA - Companies In The UK
www.companiesintheuk.co.uk
Download UK Company Information, Accounts and Directors details. Build marketing lists and find new business.
Daniella Zheleva
uk.data.directory
Last updated on, 9th February Entity type, Person. Full name, Dr Daniella Zheleva. Nationality, BRITISH. Country of residence, SCOTLAND. Year of birth ...
(PDF) A Novel Cell-Based, High-Content Assay for Phosphorylation of...
www.academia.edu
By Daniella Zheleva in High ... High-Content Assay for Phosphorylation of Lats High-Content Assay for Phosphorylation of Lats2 by Aurora A AMY EMERY,1,3 ...
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR...
abdn.pure.elsevier.com
... Ian Neil Fleming, Simon R Green, Iain McNae, Su-Ying Wu, Campbell McInnes, Daniella Zheleva, Malcolm D Walkinshaw, Peter M Fischer.
(PDF) In vitro andin vivo antitumor properties of the cyclin...
www.academia.edu
In vitro andin vivo antitumor properties of the cyclin ... Daniella Zheleva IN VIVO ANTITUMOR PROPERTIES OF THE CYCLIN DEPENDENT KINASE INHIBITOR …
GtR
gtr.rcuk.ac.uk
The Gateway to Research: The Research Councils of the UK portal onto publicly funded research
A Phase I Study Combining CDK2/9 Inhibitor CYC065 with ...ashpublications.org › blood › article › Supplement_1 › A...
ashpublications.org
Daniella Zheleva, PhD,. Daniella Zheleva, PhD. 4Cyclacel Ltd, Dundee, United Kingdom. Search for other works by this author on: This Site.
Research Publications - University of Aberdeen
pure.abdn.ac.uk
... Neil Fleming ; Simon R Green ; Iain McNae ; Su-Ying Wu ; Campbell McInnes ; Daniella Zheleva ; Malcolm D Walkinshaw ; Peter M Fischer.
An integrated pharmacokinetic-pharmacodynamic model for an Aurora...
discovery.dundee.ac.uk
... integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor. Hiroko Kamei, Robert C. Jackson, Daniella Zheleva, Fordyce A. Davidson.
Mitotic entry: Non-genetic heterogeneity exposes the requirement for...
www.oncotarget.com
https://doi.org oncotarget Claire F. Aspinall, Daniella Zheleva, Anthony Tighe, Stephen S. Taylor
Related search requests for Daniella Zheleva
| Nikolai Zhelev Hiroko Kamei Peter Fischer | Sheelagh Frame Paul Workman Shudong Wang | Geoffrey Shapiro Markus Rehm Peter Thomas |
People Forename "Daniella" (3077) Name "Zheleva" (88) |
sorted by relevance / date